GENETIC-BASIS OF MULTIDRUG RESISTANCE OF TUMOR-CELLS

被引:142
|
作者
KANE, SE
PASTAN, I
GOTTESMAN, MM
机构
[1] NCI,CELL BIOL LAB,BETHESDA,MD 20892
[2] NCI,MOLEC BIOL LAB,BETHESDA,MD 20892
关键词
actinomycin D; ATP; Chemotherapy; colchicine; doxorubicin; drug transport; evolution; introns; MDR1; gene; P-glycoprotein; transmembrane domains; vinblastine; vincristine;
D O I
10.1007/BF00762963
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Multidrug resistance in animal cells is defined as the simultaneous resistance to a variety of compounds which appear to be structurally and mechanistically unrelated. One type of multidrug resistance is characterized by the decreased accumulation of hydrophobic natural product drugs, a phenotype which is mediated by an ATP-dependent integral membrane multidrug transporter termed P-glycoprotein or P170. The gene coding for P170 is called MDR. The nucleotide-binding domain of P-glycoprotein shares sequence homology with a family of bacterial permease ATP-binding components. In addition, P170 as a whole is structurally very similar to a number of prokaryotic and eukaryotic proteins believed to be involved in transport activities. This review summarizes our current knowledge of the molecular biology and clinical significance of MDR expression and P-glycoprotein transport activity, as well as some theories about the function of this protein in normal cells. © 1990 Plenum Publishing Corporation.
引用
收藏
页码:593 / 618
页数:26
相关论文
共 50 条
  • [1] THE GENETIC-BASIS OF RESISTANCE TO CANCER-CHEMOTHERAPY
    WOODHOUSE, JR
    FERRY, DR
    ANNALS OF MEDICINE, 1995, 27 (02) : 157 - 167
  • [2] ROLE OF OXYGEN FREE-RADICAL FORMATION IN THE MECHANISM OF MENOGARIL RESISTANCE IN MULTIDRUG RESISTANT TUMOR-CELLS
    SINHA, BK
    ATWELL, J
    POLITI, PM
    CHEMICO-BIOLOGICAL INTERACTIONS, 1990, 76 (01) : 89 - 99
  • [3] MODULATION OF VINDESINE AND DOXORUBICIN RESISTANCE IN MULTIDRUG-RESISTANT PLEURAL MESOTHELIOMA CELLS BY TUMOR-NECROSIS-FACTOR-ALPHA
    LICHT, T
    LUBBERT, M
    MARTENS, C
    BROSS, KJ
    FIEBIG, HH
    MERTELSMANN, R
    HERRMANN, F
    CYTOKINES AND MOLECULAR THERAPY, 1995, 1 (02): : 123 - 132
  • [4] Cellular mechanisms of multidrug resistance of tumor cells
    Stavrovskaya, AA
    BIOCHEMISTRY-MOSCOW, 2000, 65 (01) : 95 - 106
  • [5] Effect of multidrug resistance 1/P-glycoprotein on the hypoxia-induced multidrug resistance of human laryngeal cancer cells
    Li, Dawei
    Zhou, Liang
    Huang, Jiameng
    Xiao, Xiyan
    ONCOLOGY LETTERS, 2016, 12 (02) : 1569 - 1574
  • [6] Assay for determination of daunorubicin in cancer cells with multidrug resistance phenotype
    Krumpochova, Petra
    Kocurova, Andrea
    Dolezel, Petr
    Mlejnek, Petr
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2011, 879 (21): : 1875 - 1880
  • [7] GENETIC-BASIS OF LIMITED CELL-PROLIFERATION
    KIRKWOOD, TBL
    MUTATION RESEARCH, 1991, 256 (2-6): : 323 - 328
  • [8] ANTIBODY-DIRECTED THERAPY OF MULTIDRUG-RESISTANT TUMOR-CELLS
    EFFERTH, T
    VOLM, M
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1992, 9 (01): : 11 - 19
  • [9] Modulation of multidrug resistance by cepharanthine in fresh human gastrointestinal tumor cells
    Hotta, T
    Tanimura, H
    Yamaue, H
    Iwahashi, M
    Tani, M
    Tsunoda, T
    Tamai, M
    Noguchi, K
    Mizobata, S
    Arii, K
    Terasawa, H
    ONCOLOGY, 1997, 54 (02) : 153 - 157
  • [10] Overcoming Multidrug Resistance in Cancer Stem Cells
    Moitra, Karobi
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015